400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
ChiCTR2200065390
尚未开始
/
/
/
2022-11-03
/
/
Substance abuse
Effect of additional mindfulness training to smoking cessation treatment on relapse prevention of Chinese smokers: a pragmatic randomized-controlled trial
Effect of additional mindfulness training to smoking cessation treatment on relapse prevention of Chinese smokers: a pragmatic randomized-controlled trial
To evaluate the effectiveness of a brief individual mindfulness training when added to smoking cessation treatment (i.e. nicotine replacement therapy + counseling) for preventing relapse in smoking compared to smoking cessation treatment only. Previous meta-analyses suggested having a more vigorous design in research on mindfulness training for smoking cessation (Maglione et al., 2017; Oikonomou et al., 2017). This study will be reported following the Consolidated Standards of Reporting Trials (CONSORT) standards (Schulz et al., 2010).
随机平行对照
Ⅰ期
The randomization table of each strata will be generated by an independent researcher via an online software.
none
未说明
/
45
/
2022-10-03
2024-10-03
/
1. Self-report daily smokers; 2. Receive nicotine patch treatment; 3. Motivated to quit within the next 30 days; 4. Aged >= 18 years; 5. Able to speak and read Chinese; 6. Not being pregnant.;
请登录查看1. Contraindication of nicotine patch use; 2. With significant physical illness or severe cognitive impairment that create obstacle for communication, such as blindness or severe hearing loss; 3. Actively psychotic or manic; 4. With active illicit drug use; 5. Alcohol dependence with Alcohol Use Disorders Identification Test (AUDIT) score 20 or above (World-Health-Organization, 2001); 6. Participation in mindfulness course or having daily mindfulness practice in the previous 12 months; 7. Participation in smoking cessation treatment in the previous 12 months.;
请登录查看Prince of Wales Hospital
/
皮肤好医荟2025-12-04
体外诊断原料网2025-12-04
优赛生命2025-12-04
医药时间2025-12-04
佰傲谷BioValley2025-12-04
求实药社2025-12-04
启迪之星2025-12-04
亚虹医药2025-12-04
幂方健康基金2025-12-04
汉氏联合2025-12-04